K. Yamaguchi et al., Possible mechanisms for the suppressing action of 17 beta-estradiol on beta-adrenoceptor-mediated vasorelaxation in rat aorta, EUR J PHARM, 427(1), 2001, pp. 61-67
The mode of action of estrogen on P-adrenoceptor-mediated relaxation was in
vestigated by using isolated ring preparations of thoracic aorta from ovari
ectomized rats. Administration of 17 beta -estradiol to ovariectomized rats
significantly suppressed isoprenaline-induced relaxation of aortic rings.
There was no alteration in the beta -adrenoceptor binding characteristics.
The suppressing action of 17 beta -estradiol on the N-G-nitro-L-arginine an
d indomethacin-resistant relaxation induced by isoprenaline disappeared aft
er pretreatment with N,N-di-ethylaminoethyl-2,2-diphenylvalerate hydrochlor
ide (SKF 525A), an inhibitor of cytochrome P450 (CYP). The levels of CYP2C1
1 expression were the highest of the CYP mRNAs examined in rat aorta. 17 be
ta -Estradiol replacement increased the expression of CYP2C11 mRNA in the a
orta, compared with that in ovariectomized rats. These results suggest that
estrogen suppresses beta -adrenoceptor-mediated vasorelaxation, and that t
he mechanisms may be associated with alterations in CYP2C11 metabolites. (C
) 2001 Published by Elsevier Science B.V.